This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Chr. Hansen A/s. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Dorte Myling-Petersen: Innovator in Intestinal Health
Introduction
Dorte Myling-Petersen is a prominent inventor based in Hoersholm, Denmark. She has made significant contributions to the field of intestinal health through her innovative research and patented inventions. Her work focuses on developing novel isolated strains that can enhance intestinal barrier function and address various inflammatory conditions.
Latest Patents
Dorte Myling-Petersen holds 1 patent related to her groundbreaking research. The patent describes isolated strains capable of increasing the trans-epithelial electrical resistance (TER) of a Caco-2 cell monolayer, inducing secretion of IL-10, and achieving a favorable IL-10:IL-12 ratio when co-incubated with human PBMC derived dendritic cells. These strains are intended for the prevention and treatment of diseases associated with impaired intestinal barrier function, including inflammatory bowel disease (IBD), liver diseases, metabolic disorders, autoimmune diseases, and mental health conditions.
Career Highlights
Dorte Myling-Petersen is affiliated with Chr. Hansen A/S, a leading company in the field of bioscience. Her work at the company has allowed her to explore innovative solutions for improving gut health and addressing various health challenges.
Collaborations
Throughout her career, Dorte has collaborated with notable colleagues, including Elke Brockmann and Thomas Dyrmann Leser. These partnerships have contributed to the advancement of her research and the successful development of her patented inventions.
Conclusion
Dorte Myling-Petersen is a trailblazer in the field of intestinal health, with a focus on innovative solutions for complex health issues. Her contributions through her patent and collaborations highlight her commitment to improving health outcomes related to intestinal function.